For example, overexpression of CARM1, an epigenetic enzyme and co-transcriptional activator, has been reported to predict poor prognosis in breast cancer [33] and non-small cell lung cancer [31]. The gene discussed is CARM1; the disease is non-small cell lung carcinoma.